Not Signed In -
Exelon |
rivastigmine tartrate |
Image:Rivastigmine.png Rivastigmine Systematic (IUPAC) name 2,6-dioxo-4-phenyl-piperidine-3-carbonitrile Identifiers CAS number 123441-03-2 ATC code N06DA03 PubChem 77991 DrugBank APRD00321 Chemical data Formula C14H22N2O2 Mol. weight 250.337 g/mol Pharmacokinetic data Bioavailability 96% Protein binding 40% Metabolism ? Half life 1.5 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Rivast ...
Wikipedia - [full article]
Resources
- Exelon Consumer Information (U.S. Food and Drug Administration)
Exelon News Headlines
- Patch Better for Alzheimer's Drug?
WebMD - Wed, 19 Jul 2006 05:42 EST
- Exelon Patch, The First Transdermal Therapy For Alzheimer's Disease, May Provide Promising New Approach To Treatment Of Dementia
MedicalNewsToday - Sun, 23 Jul 2006 01:00 EST
- FDA Approves The First Treatment For Dementia Of Parkinson's Disease
MedicalNewsToday - Fri, 30 Jun 2006 06:00 EST
- Exelon(R) Patch, The First Transdermal Therapy For Alzheimer's Disease, May Provide A Promising New Approach To Treatment
MedicalNewsToday - Thu, 20 Jul 2006 06:00 EST
- FDA OKs Drug for Parkinson's Dementia
WebMD - Wed, 28 Jun 2006 03:55 EST
- US advisers back Parkinson's dementia drug
Reuters - Thu, 18 May 2006 01:54 EST
- US advisers back Parkinson's dementia drug
Reuters - Wed, 17 May 2006 06:11 EST
- FDA Advisory Committee Recommends Approval Of Exelon(R) (rivastigmine Tartrate) In The Treatment Of Dementia Associated With Parkinson's Disease
MedicalNewsToday - Fri, 19 May 2006 06:00 EST
- Exelon® Granted EU Marketing Authorization As First Treatment For Dementia Associated With Parkinson''s Disease By European Commission
MedicalNewsToday - Wed, 08 Mar 2006 11:00 EST
- Alzheimer''s Drugs Aricept, Razadyne And Exelon Offer Modest Improvements, Equal Effectiveness
MedicalNewsToday - Thu, 26 Jan 2006 12:00 EST
- Trio of Drugs May Improve Alzheimer''s
WebMD - Wed, 25 Jan 2006 11:00 EST
- Alzheimer''s Drug Is Poisonous to Infants
WebMD - Wed, 20 Jul 2005 08:57 EST
email this page
print this page
bookmark this page
feedback on this page
